DOI: http://dx.doi.org/10.18203/2349-3933.ijam20192259

A study on diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function

M. Ilamaran, A. Thangadhurai, P. Suresh Kumar, Saranya Nagalingam

Abstract


Background: Diastolic heart failure, otherwise called as heart failure with preserved ejection fraction, is common finding of hypertensive heart disease, but various studies report a high incidence of diastolic heart failure in patients with type 2 diabetes mellitus in spite of the absence of coronary artery heart disease and hypertension. The objectives of the study were to determine the prevalence of dysfunction of left ventricle in diastole in type 2 diabetes mellitus patients and to compare with the non-diabetic individuals with that of asymptomatic type II diabetes patients. To assess the correlation of diastolic dysfunction in diabetes with age of patients, HbA1c levels, duration of diabetes, retinopathy, autonomic neuropathy.

Methods: A prospective cross sectional among them 50 patients were diabetics and 50 were non-diabetic controls. Diastolic dysfunction was measured with standard echocardiographic parameters and the results were computed with corresponding variables of the patients. All the variables and their data were analysed for percentage, mean, standard deviation ‘t’ test and chi square test. The ‘t’-test was used to study the quantitative data while chi square test was used to study the qualitative data.

Results: Among the study population 60% had diastolic dysfunction and 14% had diastolic dysfunction among cases and control group respectively. Diastolic dysfunction was present among 23.3% and the 76.7% of the age group groups of less than 45 and more than 45 years of age respectively. In this study poor glycaemic status was significantly associated with diastolic dysfunction, whereas duration of diabetes, retinopathy and autonomic neuropathy were not statistically significant.

Conclusions: Present study reveals moderately high incidence of diastolic dysfunction in asymptomatic diabetic; subjects and, this finding was correlated with the HBA1C levels but not with retinopathy and autonomic neuropathy.


Keywords


Autonomic neuropathy, Diabetes mellitus, Diastolic dysfunction, Glycaemic control, Retinopathy

Full Text:

PDF

References


Kazik A, Wilczek K, Poloński L. Management of diastolic heart failure. Cardiol J. 2010;17:558-65.

From AM, Scott CG, Chen HH. Changes in diastolic dysfunction in diabetes mellitus over time. Am J Cardiol. 2009;103:1463-6.

Dikshit NM, Wadia PZ, Shukla DK. Diastolic dysfunction diabetes mellitus. Nation J Med Res. 2013;3(3):249-51.

Soldatos G, Jandeleit-Dahm K, Thomson H, Formosa M, D’orsa K, Calkin AC, et al. Large artery biomechanics and diastolic dysfunctionin patients with type 2 diabetes. Diabet Med. 2011;28:54-60.

Sacre JW, Franjic B, Jellis CL, Jenkins C, Coombes JS, Marwick TH Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imag. 2010;3:1207-15.

van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, et al. Diastolic stiffness of the failing diabetic heart: Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circ. 2008;1;117:43-51.

Masugata H, Senda S, Goda F, Yoshihara Y, Yoshikawa K, Fujita N, et al. Left ventricular diastolic dysfunction in normotensive diabetic patients in various age strata. Diab Res Clin Pract. 2008;79:91-6.

Annonu AK, Fattah AA, Mokhtar MS, Ghareeb S, Elhendy A. Left ventricular systolic and diastolic functional abnormalities in asymptomatic patients with non-insulin-dependent diabetes mellitus. J Am Soc Echocardiog. 2001;14:885-91

Patil MB, Burji NP. Echocardiographic evaluation of diastolic dysfunction in asymptomatic type 2 diabetes mellitus. J Assoc Phys India. 2012;60:23-6.

Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diab Care. 2001;24(1):5-10.